KINDAI UNIVERSITY


※苗字と名前の間にスペースをあけ、入力してください

松村 謙臣マツムラ ノリオミ

プロフィール

所属部署名医学科 / 医学研究科
職名教授
学位博士(医学)
専門婦人科腫瘍学
ジャンル医療・健康/医学
コメンテータガイドhttp://www.kindai.ac.jp/meikan/2124-matsumura-noriomi.html
ホームページURL
メールアドレス
Last Updated :2017/09/14

コミュニケーション情報 byコメンテータガイド

コメント

    婦人科がん(卵巣がん、子宮頸がん、子宮体がん)の診断と治療。

研究活動情報

論文

  • PD-1/PD-L1 blockade in cancer treatment: perspectives and issues., Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I, International journal of clinical oncology, 21, 3, 462, 473,   2016年06月, 査読有り
  • Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application., Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I, International journal of clinical oncology, 21, 3, 456, 461,   2016年06月, 査読有り
  • PEP-19 overexpression in human uterine leiomyoma, T. Kanamori; K. Takakura; M. Mandai; M. Kariya; K. Fukuhara; T. Kusakari; C. Momma; H. Shime; H. Yagi; M. Konishi; A. Suzuki; N. Matsumura; K. Nanbu; J. Fujita; S. Fujii, Molecular Human Reproduction, 9, 11, 709, 717,   2003年11月, 査読有り
  • Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer., Yamanoi K, Matsumura N, Murphy SK, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Konishi I, Mandai M, Oncotarget,   2016年06月, 査読有り
  • Oncogenic property of acrogranin in human uterine leiomyosarcoma: Direct evidence of genetic contribution in in vivo tumorigenesis, N. Matsumura; M. Mandai; M. Miyanishi; K. Fukuhara; T. Baba; T. Higuchi; M. Kariya; K. Takakura; S. Fujii, Clinical Cancer Research, 12, 5, 1402, 1411,   2006年03月, 査読有り
  • Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma., Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M, Oncotarget,   2016年06月, 査読有り
  • Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes., Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I, The American journal of pathology, 186, 5, 1103, 1113,   2016年05月, 査読有り
  • Precise anatomy of the vesico-uterine ligament for radical hysterectomy, S. Fujii; K. Takakura; N. Matsumura; T. Higuchi; S. Yura; M. Mandai; T. Baba, Gynecologic Oncology, 104, 1, 186, 191,   2007年01月, 査読有り
  • Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity., Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I, Clinical cancer research : an official journal of the American Association for Cancer Research, 22, 10, 2329, 2334,   2016年05月, 査読有り
  • Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition, T. Baba; M. Kariya; T. Higuchi; M. Mandai; N. Matsumura; E. Kondoh; M. Miyanishi; K. Fukuhara; K. Takakura; S. Fujii, Gynecologic Oncology, 105, 3, 703, 711,   2007年06月, 査読有り
  • Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: Two case reports., Hino M, Yamaguchi K, Abiko K, Yoshioka Y, Hamanishi J, Kondoh E, Koshiyama M, Baba T, Matsumura N, Minamiguchi S, Kido A, Konishi I, Molecular and clinical oncology, 4, 5, 699, 704,   2016年05月, 査読有り
  • Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity, T. Baba; S. Mori; N. Matsumura; M. Kariya; S.K. Murphy; E. Kondoh; T. Kusakari; H. Kuroda; M. Mandai; T. Higuchi; K. Takakura; M.N. Fukuda; S. Fujii, Biochemical and Biophysical Research Communications, 360, 2, 363, 369,   2007年08月, 査読有り
  • The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target., Peng J, Yoshioka Y, Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Kharma B, Murakami R, Abiko K, Murphy SK, Konishi I, Molecular carcinogenesis, 55, 4, 335, 345,   2016年04月, 査読有り
  • Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy, S. Fujii; K. Takakura; N. Matsumura; T. Higuchi; S. Yura; M. Mandai; T. Baba; S. Yoshioka, Gynecologic Oncology, 107, 1, 4, 13,   2007年10月, 査読有り
  • Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer., Abou-Taleb HA, Koshiyama M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Abiko K, Yamanoi K, Murakami R, Horikawa N, Taha AA, Kitamura S, Konishi I, The Journal of international medical research, 44, 2, 346, 356,   2016年04月, 査読有り
  • Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression, M. Miyanishi; M. Mandai; N. Matsumura; K. Yamaguchi; J. Hamanishi; T. Higuchi; K. Takakura; S. Fujii, Oncology Reports, 17, 2, 329, 333,   2007年02月, 査読有り
  • Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles., Murakami R, Matsumura N, Brown JB, Wang Z, Yamaguchi K, Abiko K, Yoshioka Y, Hamanishi J, Baba T, Koshiyama M, Mandai M, Yamada R, Konishi I, Gynecologic oncology, 141, 1, 49, 56,   2016年04月, 査読有り
  • Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: Utilization for ovarian cancer treatment, N. Matsumura; M. Mandai; J. Hamanishi; K. Yamaguchi; K. Fukuhara; H. Yagi; T. Higuchi; K. Takakura; S. Fujii, Oncology Reports, 19, 2, 505, 515,   2008年02月, 査読有り
  • Tubo-ovarian abscess with endometrial cyst probably infected by Campylobacter fetus: Two cases., Kitamura S, Matsumura N, Ohtake N, Kita M, Konishi I, The journal of obstetrics and gynaecology research,   2016年04月, 査読有り
  • Two cases of Wolffian tumor with novel magnetic resonance imaging findings reflecting characteristic pathology., Sakai M, Abiko K, Matsumura N, Kondoh E, Yamaguchi K, Minamiguchi S, Kurata Y, Kido A, Konishi I, The journal of obstetrics and gynaecology research,   2016年04月, 査読有り
  • Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: High expression of ULBP2 is an indicator of poor prognosis, K. Li; M. Mandai; J. Hamanishi; N. Matsumura; A. Suzuki; H. Yagi; K. Yamaguchi; T. Baba; S. Fujii; I. Konishi, Cancer Immunology, Immunotherapy, 58, 5, 641, 652,   2009年05月, 査読有り
  • Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer., Fujiwara K, McAlpine JN, Lheureux S, Matsumura N, Oza AM, American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, 35, e247, 57,   2016年, 査読有り
  • Yin Yang 1 modulates taxane response in epithelial ovarian cancer, N. Matsumura; Z. Huang; T. Baba; P.S. Lee; J.C. Barnett; S. Mori; J.T. Chang; W.-L. Kuo; A.H. Gusberg; R.S. Whitaker; J.W. Gray; S. Fujii; A. Berchuck; S.K. Murphy, Molecular Cancer Research, 7, 2, 210, 220,   2009年02月, 査読有り
  • Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer., Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33, 34, 4015, 4022,   2015年12月, 査読有り
  • Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression, M. Liu; N. Matsumura; M. Mandai; K. Li; H. Yagi; T. Baba; A. Suzuki; J. Hamanishi; K. Fukuhara; I. Konishi, Modern Pathology, 22, 3, 373, 384,   2009年03月, 査読有り
  • Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer., Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M, Cancer research, 75, 23, 5034, 5045,   2015年12月, 査読有り
  • Isolated levocardia: Prenatal diagnosis and management, S. Katsuya; S. Yamada; M. Ukita; H. Nishimura; N. Matsumura; K. Fukuhara; Y. Sato; K. Shiota; I. Konishi, Congenital Anomalies, 49, 2, 56, 60,   2009年06月, 査読有り
  • Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction., Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T, Konishi I, Oncotarget, 6, 31, 30704, 30714,   2015年10月, 査読有り
  • Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients., Horikawa N, Baba T, Matsumura N, Murakami R, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Yoshioka Y, Konishi I, BMC cancer, 15, 739,   2015年10月, 査読有り
  • Ovarian cancer in endometriosis: Molecular biology, pathology, and clinical management, M. Mandai; K. Yamaguchi; N. Matsumura; T. Baba; I. Konishi, International Journal of Clinical Oncology, 14, 5, 383, 391,   2009年10月, 査読有り
  • Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma., Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman LD, Gabra H, Fotopoulou C, Sood AK, European journal of cancer (Oxford, England : 1990), 51, 14, 1978, 1988,   2015年09月, 査読有り
  • Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival., Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y, Konishi I, Oncotarget, 6, 28, 26002, 26017,   2015年09月, 査読有り
  • Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling, N. Matsumura; M. Mandai; T. Okamoto; K. Yamaguchi; S. Yamamura; T. Oura; T. Baba; J. Hamanishi; H.S. Kang; S. Matsui; S. Mori; S.K. Murphy; I. Konishi, Cancer Science, 101, 12, 2658, 2663,   2010年12月, 査読有り
  • Menstrual cyclic change of metastin/GPR54 in endometrium., Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I, Medical molecular morphology, 48, 2, 76, 84,   2015年06月, 査読有り
  • Suppression of Metastatic Murine Ovarian Cancer Cells by Transduced Embryonic Progenitor Cells, M. Mandai; J. Hamanishi; K. Abiko; N. Matsumura; T. Baba; Y. Yoshioka; I. Konishi, Hormones and Cancer, 1, 6, 291, 296,   2010年12月, 査読有り
  • Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging., Fujii S, Kido A, Baba T, Fujimoto K, Daido S, Matsumura N, Konishi I, Togashi K, European journal of radiology, 84, 4, 581, 589,   2015年04月, 査読有り
  • Middle cerebral artery-peak systolic velocity in dizygotic twins with anti-E alloimmunizationjog±1314 1236..1239, Y. Satake; Y. Sato; N. Matsumura; K. Tatsumi; H. Fujiwara; I. Konishi, Journal of Obstetrics and Gynaecology Research, 36, 6, 1236, 1239,   2010年12月, 査読有り
  • Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion., Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman LD, Sood AK, Gynecologic oncology, 136, 2, 198, 204,   2015年02月, 査読有り
  • Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer, J. Hamanishi; M. Mandai; N. Matsumura; T. Baba; K. Yamaguchi; S. Fujii; I. Konishi, Stem Cells, 28, 1, 164, 173,   2010年01月, 査読有り
  • Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta., Nagura M, Matsumura N, Baba T, Murakami R, Kharma B, Hamanishi J, Yamaguchi K, Abiko K, Koshiyama M, Mandai M, Murata T, Murphy SK, Konishi I, Gynecologic oncology, 136, 1, 104, 111,   2015年01月, 査読有り
  • MR imaging-based evaluation of morphological changes in the uterus and ovaries of patients following neoadjuvant chemotherapy for cervical cancer., Himoto Y, Kido A, Fujimoto K, Daido S, Kiguchi K, Shitano F, Baba T, Matsumura N, Konishi I, Togashi K, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 14, 1, 65, 72,   2015年, 査読有り
  • Targeting slow-proliferating ovarian cancer cells, E. Kondoh; S. Mori; K. Yamaguchi; T. Baba; N. Matsumura; J.C. Barnett; R.S. Whitaker; I. Konishi; S. Fujii; A. Berchuck; S.K. Murphy, International Journal of Cancer, 126, 10, 2448, 2456,   2010年05月15日, 査読有り
  • Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma., Okamoto A, Sehouli J, Yanaihara N, Hirata Y, Braicu I, Kim BG, Takakura S, Saito M, Yanagida S, Takenaka M, Yamaguchi N, Morikawa A, Tanabe H, Yamada K, Yoshihara K, Enomoto T, Itamochi H, Kigawa J, Matsumura N, Konishi I, Aida S, Aoki Y, Ishii N, Ochiai K, Akiyama T, Urashima M, PloS one, 10, 2, e0116977,   2015年, 査読有り
  • Oct4 expression in immature teratoma of the ovary: Relevance to histologic grade and degree of differentiation, K. Abiko; M. Mandai; J. Hamanishi; N. Matsumura; T. Baba; A. Horiuchi; Y. Mikami; S. Yoshioka; T. Wakasa; T. Shiozawa; I. Konishi, American Journal of Surgical Pathology, 34, 12, 1842, 1848,   2010年12月, 査読有り
  • STAT1 drives tumor progression in serous papillary endometrial cancer., Kharma B, Baba T, Matsumura N, Kang HS, Hamanishi J, Murakami R, McConechy MM, Leung S, Yamaguchi K, Hosoe Y, Yoshioka Y, Murphy SK, Mandai M, Hunstman DG, Konishi I, Cancer research, 74, 22, 6519, 6530,   2014年11月, 査読有り
  • Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer, N. Matsumura; Z. Huang; S. Mori; T. Baba; S. Fujii; I. Konishi; E.S. Iversen; A. Berchuck; S.K. Murphy, Genome Research, 21, 1, 74, 82,   2011年01月, 査読有り
  • Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary., Okamoto A, Glasspool RM, Mabuchi S, Matsumura N, Nomura H, Itamochi H, Takano M, Takano T, Susumu N, Aoki D, Konishi I, Covens A, Ledermann J, Mezzanzanica D, Steer C, Millan D, McNeish IA, Pfisterer J, Kang S, Gladieff L, Bryce J, Oza A, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 24, 9 Suppl 3, S20, 5,   2014年11月, 査読有り
  • Distinguishing primary from secondary mucinous ovarian tumors: An algorithm using the novel marker DPEP1, T. Okamoto; N. Matsumura; M. Mandai; T. Oura; Y. Yamanishi; A. Horiuchi; J. Hamanishi; T. Baba; M. Koshiyama; T. Shiozawa; I. Konishi, Modern Pathology, 24, 2, 267, 276,   2011年02月, 査読有り
  • Clear cell carcinoma arising from a uterus-like mass., Nakakita B, Abiko K, Mikami Y, Kido A, Baba T, Yoshioka Y, Yamaguchi K, Matsumura N, Konishi I, Pathology international, 64, 11, 576, 580,   2014年11月, 査読有り
  • Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype, M. Mandai; N. Matsumura; T. Baba; K. Yamaguchi; J. Hamanishi; I. Konishi, Cancer Letters, 310, 2, 129, 133,   2011年11月, 査読有り
  • Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix., Nagura M, Koshiyama M, Matsumura N, Kido A, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Mikami Y, Konishi I, BMC cancer, 14, 784,   2014年10月, 査読有り
  • Successful recovery from delayed amniotic fluid embolism with prolonged cardiac resuscitation, K. Hosono; N. Matsumura; N. Matsuda; H. Fujiwara; Y. Sato; I. Konishi, Journal of Obstetrics and Gynaecology Research, 37, 8, 1122, 1125,   2011年08月, 査読有り
  • Peritumoral enhancement in endometrial cancer on dynamic contrast-enhanced imaging: radiologic-pathologic correlation., Fujii S, Kido A, Mikami Y, Matsumura N, Konishi I, Togashi K, The journal of obstetrics and gynaecology research, 40, 5, 1445, 1449,   2014年05月, 査読有り
  • Primary squamous cell carcinoma of fallopian tube accompanied by gastric metaplasia of female genital tract: Case report and review, H. Satoh; T. Baba; M. Mandai; A. Suzuki; N. Matsumura; I. Konishi, Journal of Obstetrics and Gynaecology Research, 37, 8, 1106, 1111,   2011年08月, 査読有り
  • Assessment of the early predictive power of quantitative magnetic resonance imaging parameters during neoadjuvant chemotherapy for uterine cervical cancer., Himoto Y, Fujimoto K, Kido A, Matsumura N, Baba T, Daido S, Kiguchi K, Shitano F, Konishi I, Togashi K, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 24, 4, 751, 757,   2014年05月, 査読有り
  • The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors, J. Hamanishi; M. Mandai; K. Abiko; N. Matsumura; T. Baba; Y. Yoshioka; K. Kosaka; I. Konishi, Clinical Immunology, 141, 3, 338, 347,   2011年12月, 査読有り
  • Recent concepts of ovarian carcinogenesis: type I and type II., Koshiyama M, Matsumura N, Konishi I, BioMed research international, 2014, 934261,   2014年, 査読有り
  • GPR54 is a target for suppression of metastasis in endometrial cancer, H.S. Kang; T. Baba; M. Mandai; N. Matsumura; J. Hamanishi; B. Kharma; E. Kondoh; Y. Yoshioka; S. Oishi; N. Fujii; S.K. Murphy; I. Konishi, Molecular Cancer Therapeutics, 10, 4, 580, 590,   2011年04月, 査読有り
  • Epigenetic and genetic dispositions of ovarian carcinomas., Yamaguchi K, Matsumura N, Mandai M, Baba T, Konishi I, Murphy SK, Oncoscience, 1, 9, 574, 579,   2014年, 査読有り
  • Transcription factor POU6F1 is important for proliferation of clear cell adenocarcinoma of the ovary and is a potential new molecular target., Suzuki N, Yoshioka N, Uekawa A, Matsumura N, Tozawa A, Koike J, Konishi I, Kiguchi K, Ishizuka B, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 20, 2, 212, 219,   2010年02月, 査読有り
  • Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta, N. Matsumura; T. Inoue; M. Fukuoka; N. Sagawa; S. Fujii, Journal of Obstetrics and Gynaecology Research, 26, 2, 81, 87,   2000年, 査読有り
  • The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer, S. Yamamura; N. Matsumura; M. Mandai; Z. Huang; T. Oura; T. Baba; J. Hamanishi; K. Yamaguchi; H.S. Kang; T. Okamoto; K. Abiko; S. Mori; S.K. Murphy; I. Konishi, International Journal of Cancer, 130, 1, 20, 28,   2012年01月, 査読有り
  • Severe congenital cytomegalovirus infection with fetal hydrops in a cytomegalovirus-seropositive healthy woman, T. Inoue; N. Matsumura; M. Fukuoka; N. Sagawa; S. Fujii, European Journal of Obstetrics Gynecology and Reproductive Biology, 95, 2, 184, 186,   2001年, 査読有り
  • Advanced extragonadal yolk sac tumor serially followed up with 18F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein, T. Baba; S. Su; S. Umeoka; K. Abiko; Y. Nakamoto; M. Mandai; N. Matsumura; I. Konishi, Journal of Obstetrics and Gynaecology Research, 38, 3, 605, 609,   2012年03月, 査読有り
  • Solitary fibrous tumor arising slowly in the vulva over 10 years: Case report and review, M. Taki; T. Baba; M. Mandai; A. Suzuki; Y. Mikami; N. Matsumura; I. Konishi, Journal of Obstetrics and Gynaecology Research, 38, 5, 884, 888,   2012年05月, 査読有り
  • High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway, K. Yoshihara; T. Tsunoda; D. Shigemizu; H. Fujiwara; M. Hatae; H. Fujiwara; H. Masuzaki; H. Katabuchi; Y. Kawakami; A. Okamoto; T. Nogawa; N. Matsumura; Y. Udagawa; T. Saito; H. Itamochi; M. Takano; E. Miyagi; T. Sudo; K. Ushijima; H. Iwase; H. Seki; Y. Terao; T. Enomoto; M. Mikami; K. Akazawa; H. Tsuda; T. Moriya; A. Tajima; I. Inoue; K. Tanaka, Clinical Cancer Research, 18, 5, 1374, 1385,   2012年03月, 査読有り
  • Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas, T.-H. Chen; K. Fukuhara; M. Mandai; N. Matsumura; M. Kariya; K. Takakura; S. Fujii, International Journal of Gynecological Cancer, 16, 2, 772, 779,   2006年, 査読有り
  • Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis, K. Yamanoi; M. Mandai; A. Suzuki; N. Matsumura; T. Baba; Y. Yoshioka; K. Kosaka; I. Konishi, Oncology Letters, 4, 3, 375, 380,   2012年09月, 査読有り
  • Adenoid cystic carcinoma of skene glands: A rare origin in the female genital tract and the characteristic clinical course, Y. Ueda; M. Mandai; N. Matsumura; T. Baba; A. Suzuki; Y. Yoshioka; K. Kosaka; I. Konishi, International Journal of Gynecological Pathology, 31, 6, 596, 600,   2012年11月, 査読有り
  • Histotype-specific copy-number alterations in ovarian cancer, R.Y. Huang; G.B. Chen; N. Matsumura; H.-C. Lai; S. Mori; J. Li; M.K. Wong; I. Konishi; J.-P. Thiery; L.K. Goh, BMC Medical Genomics, 5, 47-,   2012年10月, 査読有り
  • Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development., A. Suzuki; M. Kariya; N. Matsumura; T. Baba; H. Yagi; M. Mandai; I. Konishi; S. Fujii, Medical molecular morphology, 45, 4, 214, 221,   2012年12月, 査読有り
  • [Molecular mechanisms of peritoneal dissemination in ovarian cancer]., N. Matsumura; M. Mandai; T. Baba; I. Konishi, Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 4, 498, 501,   2012年06月, 査読有り
  • [Clinical management of fallopian tube cancer]., M. Mandai; N. Matsumura; T. Baba; A. Suzuki; I. Konishi, Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 4, 664, 669,   2012年06月, 査読有り
  • Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells, T. Baba; P.A. Convery; N. Matsumura; R.S. Whitaker; E. Kondoh; T. Perry; Z. Huang; R.C. Bentley; S. Mori; S. Fujii; J.R. Marks; A. Berchuck; S.K. Murphy, Oncogene, 28, 2, 209, 218,   2009年, 査読有り
  • Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer, T.Z. Tan; Q.H. Miow; R.Y.-J. Huang; M.K. Wong; J. Ye; J.A. Lau; M.C. Wu; L.H. Bin Abdul Hadi; R. Soong; M. Choolani; B. Davidson; J.M. Nesland; L.-Z. Wang; N. Matsumura; M. Mandai; I. Konishi; B.-C. Goh; J.T. Chang; J.P. Thiery; S. Mori, EMBO Molecular Medicine, 5, 7, 983, 998,   2013年07月, 査読有り
  • Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers, B. Kharma; T. Baba; M. Mandai; N. Matsumura; S.K. Murphy; H.S. Kang; K. Yamanoi; J. Hamanishi; K. Yamaguchi; Y. Yoshioka; I. Konishi, International Journal of Cancer, 133, 9, 2234, 2244,   2013年11月, 査読有り
  • Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report, Y. Amano; M. Mandai; T. Baba; J. Hamanishi; Y. Yoshioka; N. Matsumura; I. Konishi, Oncology Letters, 6, 5, 1241, 1244,   2013年11月, 査読有り
  • Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma, T. Okamoto; M. Mandai; N. Matsumura; K. Yamaguchi; H. Kondoh; Y. Amano; T. Baba; J. Hamanishi; K. Abiko; K. Kosaka; S.K. Murphy; S. Mori; I. Konishi, Molecular Carcinogenesis, 54, 1, 35, 49,   2013年, 査読有り
  • A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography, K. Yamanoi; N. Matsumura; A. Kido; T. Baba; J. Hamanishi; K. Yamaguchi; Y. Yoshioka; H.A. Taleb; K. Togashi; I. Konishi, Gynecologic Oncology, 131, 3, 701, 707,   2013年12月, 査読有り
  • Anchorage-independent cell growth signature identifies tumors with metastatic potential, S. Mori; J.T. Chang; E.R. Andrechek; N. Matsumura; T. Baba; G. Yao; J.W. Kim; M. Gatza; S. Murphy; J.R. Nevins, Oncogene, 28, 31, 2796, 2805,   2009年, 査読有り
  • Eph-ephrin A system regulates human choriocarcinomayderived JEG-3 cell invasion, H. Fujiwara; Y. Nishioka; H. Matsumoto; K. Suginami; A. Horie; H. Tani; N. Matsumura; T. Baba; Y. Sato; Y. Araki; I. Konishi, International Journal of Gynecological Cancer, 23, 3, 576, 582,   2013年03月, 査読有り
  • Transcription factor POU6F1 is important for proliferation of clear cell adenocarcinoma of the ovary and is a potential new molecular target, N. Suzuki; N. Yoshioka; A. Uekawa; N. Matsumura; A. Tozawa; J. Koike; I. Konishi; K. Kiguchi; B. Ishizuka, International Journal of Gynecological Cancer, 20, 2, 212, 219,   2010年, 査読有り
  • PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction, K. Abiko; M. Mandai; J. Hamanishi; Y. Yoshioka; N. Matsumura; T. Baba; K. Yamaguchi; R. Murakami; A. Yamamoto; B. Kharma; K. Kosaka; I. Konishi, Clinical Cancer Research, 19, 6, 1363, 1374,   2013年03月15日, 査読有り
  • Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib, M. Koshiyama; N. Matsumura; T. Baba; K. Yamaguchi; Y. Yoshioka; I. Konishi, Cancer Biology and Therapy, 15, 1, 22, 25,   2014年01月, 査読有り
  • Epigenetic determinants of ovarian clear cell carcinoma biology, K. Yamaguchi; Z. Huang; N. Matsumura; M. Mandai; T. Okamoto; T. Baba; I. Konishi; A. Berchuck; S.K. Murphy, International Journal of Cancer, 135, 3, 585, 597,   2014年08月, 査読有り
  • Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component, S. Takamatsu; N. Matsumura; T. Baba; M. Mandai; Y. Mikami; I. Konishi, Journal of Obstetrics and Gynaecology Research, 40, 1, 263, 267,   2014年01月, 査読有り
  • Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes, K. Yamaguchi; M. Mandai; T. Oura; N. Matsumura; J. Hamanishi; T. Baba; S. Matsui; S.K. Murphy; I. Konishi, Oncogene, 29, 12, 1741, 1752,   2010年03月, 査読有り
  • ASGO 2nd international workshop on gynecologic oncology, N. Matsumura; M. Mandai; I. Konishi, Journal of Gynecologic Oncology, 24, 1, 3, 6,   2012年, 査読有り
  • An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530), R.Y.-J. Huang; M.K. Wong; T.Z. Tan; K.T. Kuay; A.H. C Ng; V.Y. Chung; Y.-S. Chu; N. Matsumura; H.-C. Lai; Y.F. Lee; W.-J. Sim; C. Chai; E. Pietschmann; S. Mori; J.J.H. Low; M. Choolani; J.P. Thiery, Cell Death and Disease, 4, 11,   2013年, 査読有り